Reuters logo
8 months ago
BRIEF-Abivax reports new preclinical data supporting ABX464 as HIV functional cure and novel treatment for inflammatory diseases
December 8, 2016 / 5:24 PM / 8 months ago

BRIEF-Abivax reports new preclinical data supporting ABX464 as HIV functional cure and novel treatment for inflammatory diseases

Dec 8 (Reuters) - Abivax SA :

* Abivax reports new preclinical data supporting ABX464 as hiv functional cure and novel treatment for inflammatory diseases at HIV DART meeting

* Announcing proof-of-concept clinical trial of ABX464 to treat inflammatory bowel disease (IBD)

* ABX464 upregulates IL-22 and MIR-124 suggesting strong anti-inflammatory effect, broadening therapeutic potential

* New preclinical data supporting ABX464 as HIV functional cure and novel treatment for inflammatory diseases at HIV DART meeting Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below